These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2483016)

  • 1. [Immunomodulator treatment of multibacillary leprosy using extracts of microbial ribosomes].
    Saint-André P; Baquillon G; David M
    Acta Leprol; 1989; 7(1):57-8. PubMed ID: 2483016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of an immunomodulant, isoprinosine, in multibacillary leprosy. Preliminary study].
    Saint-André P; Ferracci C; Ridel PR; Baquillon C; Boucher P
    Acta Leprol; 1982; (86-87):113-29. PubMed ID: 6183917
    [No Abstract]   [Full Text] [Related]  

  • 6. Fixed duration therapy (FDT) in MB leprosy (clinicobacteriological experience).
    Vijayakumaran P
    Indian J Lepr; 1996; 68(3):297-300. PubMed ID: 8889617
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune modulators as antiviral agents.
    Steele RW; Charlton RK
    Clin Lab Med; 1987 Dec; 7(4):911-24. PubMed ID: 2446821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of levamisole, an immunopotentiator, in the treatment of lepromatous leprosy.
    Kar HK; Bhatia VN; Kumar CH; Sirumban P; Roy RG
    Indian J Lepr; 1986; 58(4):592-600. PubMed ID: 3572102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS; Bhanage ND; Sawant KV; Ganapati R
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leprosy: identification of an isolated case].
    Fernández Galán MA; Borbujo Martínez J; Fernández Capitán MC; Casado Jiménez M
    Rev Clin Esp; 1992 Jan; 190(1):24-6. PubMed ID: 1546198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current views on reactions in leprosy.
    Naafs B
    Indian J Lepr; 2000; 72(1):97-122. PubMed ID: 10935190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.